Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2019

01-12-2019 | Mastectomy | ASO Author Reflections

ASO Author Reflections: Malignant/Borderline Phyllodes Tumors Without Uniformly Poor Histologic Features Have an Excellent Prognosis

Authors: Philip M. Spanheimer, MD, Andrea V. Barrio, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2019

Login to get access

Excerpt

Malignant/borderline phyllodes tumors of the breast are rare neoplasms with poorly understood prognosis following surgical excision. Rates of reported local and distant recurrence are widely variable in the literature due to changes in the grading of phyllodes tumors over time, as well as to subjectivity in grading attributed to overlapping histologic features and tumor heterogeneity.1 In addition, the current literature has failed to identify reproducible clinical and pathologic factors associated with both local and distant recurrence, limiting our ability to identify a ‘high-risk’ cohort of patients who may be at higher risk for recurrence. We reviewed our single-institution experience with malignant/borderline phyllodes tumors, treated predominantly without adjuvant therapy, to assess the rates of local and distant recurrence, and to identify factors associated with recurrence. …
Literature
1.
go back to reference Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E, et al. Phyllodes tumours of the breast: a consensus review. Histopathology. 2016;68(1):5–21.CrossRef Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E, et al. Phyllodes tumours of the breast: a consensus review. Histopathology. 2016;68(1):5–21.CrossRef
3.
go back to reference Gnerlich JL, Williams RT, Yao K, Jaskowiak N, Kulkarni SA. Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998–2009. Ann Surg Oncol. 2014;21(4):1222–30.CrossRef Gnerlich JL, Williams RT, Yao K, Jaskowiak N, Kulkarni SA. Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998–2009. Ann Surg Oncol. 2014;21(4):1222–30.CrossRef
4.
go back to reference Kim YJ, Kim K. Radiation therapy for malignant phyllodes tumor of the breast: an analysis of SEER data. Breast. 2017;32:26–32.CrossRef Kim YJ, Kim K. Radiation therapy for malignant phyllodes tumor of the breast: an analysis of SEER data. Breast. 2017;32:26–32.CrossRef
5.
go back to reference Macdonald OK, Lee CM, Tward JD, Chappel CD, Gaffney DK. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer. 2006;107(9):2127–33.CrossRef Macdonald OK, Lee CM, Tward JD, Chappel CD, Gaffney DK. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer. 2006;107(9):2127–33.CrossRef
Metadata
Title
ASO Author Reflections: Malignant/Borderline Phyllodes Tumors Without Uniformly Poor Histologic Features Have an Excellent Prognosis
Authors
Philip M. Spanheimer, MD
Andrea V. Barrio, MD
Publication date
01-12-2019
Publisher
Springer International Publishing
Keyword
Mastectomy
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07459-9

Other articles of this Special Issue 3/2019

Annals of Surgical Oncology 3/2019 Go to the issue